var data={"title":"Zinc sulfate: Drug information","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"drugTitle\">Zinc sulfate: Drug information</div><div id=\"lexiTitleImg\"></div><div class=\"clear\"></div><div id=\"lcoSearchClickUrl\"><a href=\"http://online.lexi.com/lco/action/api/find/globalid/7180?utd=1\" target=\"_blank\">Access Lexicomp Online here.</a></div><div id=\"drugCopy\">Copyright 1978-2018 Lexicomp, Inc. All rights reserved.</div><div id=\"topicText\">(For additional information <a href=\"topic.htm?path=zinc-sulfate-patient-drug-information\" class=\"drug drug_patient\">see &quot;Zinc sulfate: Patient drug information&quot;</a> and <a href=\"topic.htm?path=zinc-sulfate-pediatric-drug-information\" class=\"drug drug_pediatric\">see &quot;Zinc sulfate: Pediatric drug information&quot;</a>)<br></br>For abbreviations and symbols that may be used in Lexicomp (<a href=\"image.htm?imageKey=DRUG%2F57469\" class=\"graphic graphic_table\">show table</a>)<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F235812\" class=\"list ubnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: US</span>\n    <ul>\n      <li>Eye-Sed [OTC] [DSC];</li>\n      <li>Orazinc [OTC];</li>\n      <li>Zinc 15 [OTC];</li>\n      <li>Zinc-220 [OTC]</li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F235813\" class=\"list cbnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: Canada</span>\n    <ul>\n      <li>Anuzinc;</li>\n      <li>Rivasol</li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F235819\" class=\"ex_sect_xr thclist drugH1Div drugBrandNames\"><span class=\"drugH1\">Pharmacologic Category</span>\n    <ul>\n      <li>\n        Trace Element</li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F235814\" class=\"block doa drugH1Div\"><span class=\"drugH1\">Dosing: Adult</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Dietary supplement:</b> Oral: 50 mg (dose expressed as elemental zinc) once daily</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Parenteral nutrition additive, maintenance requirement: </b>IV (dose expressed as elemental zinc):</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <i>Acute metabolic states:</i> 4.5 to 6 mg/day</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <i>Metabolically stable:</i> 2.5 to 5 mg/day (ASPEN [Vanek 2012])</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <i>Replacement for small bowel fluid loss (metabolically stable):</i> An additional 12.2 mg zinc/L of fluid lost, or an additional 17.1 mg zinc per kg of stool or ileostomy output</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Zinc deficiency (Saper 2009):</b> Oral: Some clinicians recommend daily doses of 2 to 3 times the zinc RDA for mild deficiency and 4 to 5 times the RDA for moderate to severe deficiency for 6 months.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F235816\" class=\"block dop drugH1Div\"><span class=\"drugH1\">Dosing: Pediatric</span><p>(For additional information <a href=\"topic.htm?path=zinc-sulfate-pediatric-drug-information\" class=\"drug drug_pediatric\">see &quot;Zinc sulfate: Pediatric drug information&quot;</a>)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Parenteral nutrition additive, maintenance requirement (ASPEN [Vanek 2012]):</b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Infants &lt;3 months: 250 mcg/kg/day</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Infants &ge;3 months: 50 mcg/kg/day</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Children: 50 mcg/kg/day; maximum daily dose: 5,000 mcg/day</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F235815\" class=\"block doe drugH1Div\"><span class=\"drugH1\">Dosing: Geriatric</span>\n    <p style=\"text-indent:0em;display:inline\">Refer to adult dosing.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F235804\" class=\"block foc drugH1Div\"><span class=\"drugH1\">Dosage Forms</span>\n    <p style=\"text-indent:0em;text-align:justify;display:inline\">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.  [DSC] = Discontinued product</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Capsule, Oral: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Orazinc: 220 mg</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Zinc-220: 220 mg</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Generic: 220 mg</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Solution, Intravenous: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Generic: 1 mg/mL (10 mL [DSC]); 5 mg/mL (5 mL)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Solution, Ophthalmic: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Eye-Sed: 0.217% (15 mL [DSC]) [contains benzalkonium chloride, boric acid]</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Tablet, Oral: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Orazinc: 110 mg</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Zinc 15: 66 mg</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Generic: 220 mg</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Tablet, Oral [preservative free]: </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Generic: 220 mg</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F235793\" class=\"block geq drugH1Div\"><span class=\"drugH1\">Generic Equivalent Available (US)</span>\n    <p style=\"text-indent:0em;display:inline\">Yes</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F21963760\" class=\"block dosfc drugH1Div\"><span class=\"drugH1\">Dosage Forms Considerations</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Strength of zinc sulfate injection is expressed as elemental zinc</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Oral zinc sulfate is approximately 23% elemental zinc</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F235805\" class=\"block use drugH1Div\"><span class=\"drugH1\">Use</span>\n    <p style=\"text-indent:0em;display:inline\">Trace element added to parenteral nutrition (PN) to prevent deficiency; orally as a dietary supplement.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F554161\" class=\"block mst drugH1Div\"><span class=\"drugH1\">Medication Safety Issues</span>\n    <div class=\"collapsible\">\n      <span class=\"collapsible-title\">Sound-alike/look-alike issues: </span>\n      <div class=\"collapsible-wrap\">\n        <p style=\"text-indent:-2em;margin-left:4em;\">ZnSO<sub>4</sub> is an error-prone abbreviation (mistaken as  morphine sulfate)</p></div>\r\n</div>\r\n</div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F235798\" class=\"block adr drugH1Div\"><span class=\"drugH1\">Adverse Reactions</span>\n    <p style=\"text-indent:0em;display:inline\">Frequency not defined.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Central nervous system: Dizziness, headache</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Gastrointestinal: Abdominal cramps, diarrhea, nausea, vomiting</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F13881522\" class=\"block coi drugH1Div\"><span class=\"drugH1\">Contraindications</span>\n    <p style=\"text-indent:0em;\">Injection: Do not administer undiluted into peripheral vein</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F13881523\" class=\"block war drugH1Div\"><span class=\"drugH1\">Warnings/Precautions</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Disease-related concerns:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Renal impairment: Use with caution in patients with renal impairment.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Concurrent drug therapy issues:</i></b></p>\n    <p style=\"text-indent:-4em;margin-left:6em;\">&bull; Copper: IV administration of zinc without copper may cause a decrease in copper serum concentrations.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>\n        <i>Dosage form specific issues:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&bull; Aluminum: The parenteral product may contain aluminum; toxic aluminum concentrations may be seen with high doses, prolonged use, or renal dysfunction. Premature neonates are at higher risk due to immature renal function and aluminum intake from other parenteral sources. Parenteral aluminum exposure of &gt;4 to 5 mcg/kg/day is associated with CNS and bone toxicity; tissue loading may occur at lower doses (Federal Register, 2002). See manufacturer&rsquo;s labeling.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F13300239\" class=\"block cyt drugH1Div\"><span class=\"drugH1\">Metabolism/Transport Effects</span>\n    <p style=\"text-indent:0em;display:inline\">None known.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F6223740\" class=\"block dri drugH1Div\"><span class=\"drugH1\">Drug Interactions</span>\n    <br/><br/><div id=\"lexiInteractAddInfo\" class=\"lexi\">(For additional information: <a href=\"https://www.uptodate.com/drug-interactions/?search=&amp;topicId=10328&amp;source=responsive_topic\" class=\"dip\" target=\"_blank\">Launch drug interactions program</a>)</div><div id=\"lexiInteractImgB\" class=\"lexi\"><img src=\"/images/lexiComp/Lexicomp_2012_71x17.gif\" width=\"71\" height=\"17\" border=\"0\"/></div><div class=\"clear\"></div><p style=\"text-indent:-2em;margin-left:2em;\">Ceftibuten: Zinc Salts may decrease the serum concentration of Ceftibuten.  Management: Consider administering oral zinc salts at least 3 hours after ceftibuten.<i> Risk D: Consider therapy modification</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Cephalexin: Zinc Salts may decrease the absorption of Cephalexin.  Management: Consider administering oral zinc salts at least 3 hours after cephalexin.<i> Risk D: Consider therapy modification</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Deferiprone: Zinc Salts may decrease the serum concentration of Deferiprone.  Management: Separate administration of deferiprone and oral medications or supplements that contain polyvalent cations by at least 4 hours.<i> Risk D: Consider therapy modification</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Dolutegravir: Zinc Salts may decrease the serum concentration of Dolutegravir.  Management: Administer dolutegravir at least 2 hours before or 6 hours after oral zinc salts. Administer the dolutegravir/rilpivirine combination product at least 4 hours before or 6 hours after oral zinc salts.<i> Risk D: Consider therapy modification</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Eltrombopag: Zinc Salts may decrease the serum concentration of Eltrombopag.  Management: Administer eltrombopag at least 2 hours before or 4 hours after oral administration of any zinc-containing product.<i> Risk D: Consider therapy modification</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Quinolones: Zinc Salts may decrease the serum concentration of Quinolones.  Management: Give oral quinolones at least several hours before (4 h for moxi- and sparfloxacin, 2 h for others) or after (8 h for moxi-, 6 h for cipro/dela-, 4 h for lome-, 3 h for gemi-, and 2 h for levo-, nor-, pe- or ofloxacin or nalidixic acid) oral zinc salts.<b> Exceptions: </b>LevoFLOXacin (Oral Inhalation).<i> Risk D: Consider therapy modification</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Tetracyclines: Zinc Salts may decrease the absorption of Tetracyclines. Only a concern when both products are administered orally.  Management: Consider doxycycline as a noninteracting tetracycline derivative. Separate dose administration of oral tetracycline derivative and oral zinc salts by at least 2 hours to minimize interaction.<b> Exceptions: </b>Doxycycline.<i> Risk D: Consider therapy modification</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Trientine: May decrease the serum concentration of Zinc Salts. Zinc Salts may decrease the serum concentration of Trientine.<i> Risk D: Consider therapy modification</i></p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F235811\" class=\"block foi drugH1Div\"><span class=\"drugH1\">Food Interactions</span>\n    <p style=\"text-indent:0em;display:inline\">Avoid foods high in calcium or phosphorus.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F235800\" class=\"block prf drugH1Div\"><span class=\"drugH1\">Pregnancy Risk Factor</span>\n    <p style=\"text-indent:0em;display:inline\">C (<a href=\"image.htm?imageKey=DRUG%2F50021\" class=\"graphic graphic_table\">show table</a>)</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F13881520\" class=\"block pri drugH1Div\"><span class=\"drugH1\">Pregnancy Implications</span>\n    <p style=\"text-indent:0em;display:inline\">Zinc crosses the placenta and can be measured in the cord blood and placenta. Fetal concentrations are regulated by the placenta (de Moraes, 2011).</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F13881521\" class=\"block brc drugH1Div\"><span class=\"drugH1\">Breast-Feeding Considerations</span>\n    <p style=\"text-indent:0em;display:inline\">Zinc is found in breast milk; concentrations decrease over the first 6 months of lactation. Concentrations are generally not affected by dietary supplementation (IOM, 2000).</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F235808\" class=\"block dic drugH1Div\"><span class=\"drugH1\">Dietary Considerations</span>\n    <p style=\"text-indent:0em;display:inline\">May be taken with food if GI upset occurs.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Dietary adequate intake (AI)</b> <b>(IOM 2001)<b>:</b></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">1 to 6 months: 2 mg/day</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Dietary recommended daily allowance (RDA) (IOM 2001): </b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">7 to 12 months: 3 mg/day</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">1 to 3 years: 3 mg/day</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">4 to 8 years: 5 mg/day</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">9 to 13 years: 8 mg/day</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">14 to 18 years: Females: 9 mg/day; Males: 11 mg/day; Pregnancy 12 mg/day; Lactation: 13 mg/day</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Adults &ge;19 years: Females: 8 mg/day: Males: 11 mg/day; Pregnancy: 11 mg/day; Lactation: 12 mg/day</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F50858837\" class=\"block mop drugH1Div\"><span class=\"drugH1\">Monitoring Parameters</span>\n    <p style=\"text-indent:0em;display:inline\">Patients on parenteral nutrition or chronic therapy should have periodic serum copper and serum zinc levels; alkaline phosphatase, taste acuity, mental depression</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F46169264\" class=\"block phk drugH1Div\"><span class=\"drugH1\">Pharmacodynamics/Kinetics</span>\n    <p style=\"text-indent:0em;\">Absorption: pH-dependent; enhanced at lower pH; (pH &lt;3); impaired by food (Anderson 1998)</p>\n    <p style=\"text-indent:0em;\">Distribution: Storage sites are liver and skeletal muscle; serum levels do not adequately reflect whole-body zinc status</p>\n    <p style=\"text-indent:0em;\">Protein binding: 55% bound to albumin; 40% bound to alpha 1-macroglobulin</p>\n    <p style=\"text-indent:0em;\">Excretion: Primarily in feces (Anderson,1998)</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F235807\" class=\"block fee drugH1Div\"><span class=\"drugH1\">Pricing: US</span>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Capsules</b> (Orazinc Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">220 (50 Zn) mg (100): $7.85</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Capsules</b> (Zinc Sulfate Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">220 (50 Zn) mg (100): $2.65</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Solution</b> (Zinc Sulfate Intravenous)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">1 mg/mL (10 mL): $31.90</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">5 mg/mL (5 mL): $58.60</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Tablets</b> (Orazinc Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">110 mg (100): $4.41</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Tablets</b> (Zinc 15 Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">66 mg (100): $2.18</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Tablets</b> (Zinc Sulfate Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">220 (50 Zn) mg (100): $5.40</p>\n    <p style=\"text-indent:0em;\">\n      <b>Disclaimer: </b>A representative AWP (Average Wholesale Price) price or price range is provided as reference price only. A range is provided when more than one manufacturer's AWP price is available and uses the low and high price reported by the manufacturers to determine the range. The pricing data should be used for benchmarking purposes only, and as such should not be used alone to set or adjudicate any prices for reimbursement or purchasing functions or considered to be an exact price for a single product and/or manufacturer.  Medi-Span expressly disclaims all warranties of any kind or nature, whether express or implied, and assumes no liability with respect to accuracy of price or price range data published in its solutions.  In no event shall Medi-Span be liable for special, indirect, incidental, or consequential damages arising from use of price or price range data.  Pricing data is updated monthly.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F2869420\" class=\"list fbnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: International</span>\n    <ul>\n      <li>Afazol Z (MX);</li>\n      <li>Ascazin (LK);</li>\n      <li>Avazinc (IL);</li>\n      <li>Dalidome (MX);</li>\n      <li>Daribur (MX);</li>\n      <li>Daryazinc (ID);</li>\n      <li>Exastrin (MX);</li>\n      <li>L-Zinc (ID);</li>\n      <li>Litezinc (KR);</li>\n      <li>Solvazinc (GB);</li>\n      <li>Solvezink (NO, SE);</li>\n      <li>Vytral (MX);</li>\n      <li>Z Span (AE);</li>\n      <li>Zimor (LK);</li>\n      <li>Zinchydra (ZW);</li>\n      <li>Zincocet DT (ZW);</li>\n      <li>Zincol (IL, ZW);</li>\n      <li>Zincteral (CZ, PL);</li>\n      <li>Zine (LK)</li></ul></div>\r\n</div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\">\r\n<li>\r\n<div class=\"reference\">\n    Aluminum in large and small volume parenterals used in total parenteral nutrition. <i>Fed Regist</i>. 2002;67(244):77792-77793. To be codified at 21 CFR &sect;201.323.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Anderson LA, Hakojarvi SL, Boudreaux SK. Zinc acetate treatment in Wilson's disease. <i>Ann Pharmacother</i>. 1998;32(1):78-87.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/zinc-sulfate-drug-information/abstract-text/9475826/pubmed\" target=\"_blank\" id=\"9475826\">9475826</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    de Moraes ML, de Faria Barbosa R, Santo RE, et al, &quot;Maternal-Fetal Distribution of Calcium, Iron, Copper, and Zinc in Pregnant Teenagers and Adults,&quot; <i>Biol Trace Elem Res</i>, 2011, 139(2):126-36.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/zinc-sulfate-drug-information/abstract-text/20195918/pubmed\" target=\"_blank\" id=\"20195918\">20195918</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Institute of Medicine (US) Panel on Micronutrients. <i>Dietary Reference Intakes for Vitamin A, Vitamin K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, Nickel, Silicon, Vanadium, and Zinc</i>. Washington, DC: National Academies Press; 2001. Available at <a href=\"https://www.ncbi.nlm.nih.gov/books/NBK222310/%20\" target=\"_blank\">https://www.ncbi.nlm.nih.gov/books/NBK222310/ </a></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Livingstone C. Zinc: physiology, deficiency, and parenteral nutrition. <i>Nutr Clin Pract</i>. 2015;30(3):371-382.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/zinc-sulfate-drug-information/abstract-text/25681484/pubmed\" target=\"_blank\" id=\"25681484\">25681484</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Vanek VW, Borum P, Buchman A, et al. A.S.P.E.N. position paper: recommendations for changes in commercially available parenteral multivitamin and multi-trace element products. <i>Nutr Clin Pract</i>. 2012;27:440-491.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/zinc-sulfate-drug-information/abstract-text/22730042/pubmed\" target=\"_blank\" id=\"22730042\">22730042</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Saper RB, Rash R. Zinc: an essential micronutrient. <i>Am Fam Physician</i>. 2009;79(9):768-772.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/zinc-sulfate-drug-information/abstract-text/20141096/pubmed\" target=\"_blank\" id=\"20141096\">20141096</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Zinc sulfate tablet [prescribing informtion]. Iselin, NJ: Nationwide Laboratories, LLC.; April 2016.</div>\r\n</li></ol></div><div id=\"topicVersionRevision\">Topic 10328 Version 138.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul><li class=\"plainItem\"><a sectionName=\"Brand Names: US\" href=\"#F235812\" class=\"outlineLink\">Brand Names: US</a></li><li class=\"plainItem\"><a sectionName=\"Brand Names: Canada\" href=\"#F235813\" class=\"outlineLink\">Brand Names: Canada</a></li><li class=\"plainItem\"><a sectionName=\"Pharmacologic Category\" href=\"#F235819\" class=\"outlineLink\">Pharmacologic Category</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Adult\" href=\"#F235814\" class=\"outlineLink\">Dosing: Adult</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Pediatric\" href=\"#F235816\" class=\"outlineLink\">Dosing: Pediatric</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Geriatric\" href=\"#F235815\" class=\"outlineLink\">Dosing: Geriatric</a></li><li class=\"plainItem\"><a sectionName=\"Dosage Forms\" href=\"#F235804\" class=\"outlineLink\">Dosage Forms</a></li><li class=\"plainItem\"><a sectionName=\"Generic Equivalent Available (US)\" href=\"#F235793\" class=\"outlineLink\">Generic Equivalent Available (US)</a></li><li class=\"plainItem\"><a sectionName=\"Dosage Forms Considerations\" href=\"#F21963760\" class=\"outlineLink\">Dosage Forms Considerations</a></li><li class=\"plainItem\"><a sectionName=\"Use\" href=\"#F235805\" class=\"outlineLink\">Use</a></li><li class=\"plainItem\"><a sectionName=\"Medication Safety Issues\" href=\"#F554161\" class=\"outlineLink\">Medication Safety Issues</a></li><li class=\"plainItem\"><a sectionName=\"Adverse Reactions\" href=\"#F235798\" class=\"outlineLink\">Adverse Reactions</a></li><li class=\"plainItem\"><a sectionName=\"Contraindications\" href=\"#F13881522\" class=\"outlineLink\">Contraindications</a></li><li class=\"plainItem\"><a sectionName=\"Warnings/Precautions\" href=\"#F13881523\" class=\"outlineLink\">Warnings/Precautions</a></li><li class=\"plainItem\"><a sectionName=\"Metabolism/Transport Effects\" href=\"#F13300239\" class=\"outlineLink\">Metabolism/Transport Effects</a></li><li class=\"plainItem\"><a sectionName=\"Drug Interactions\" href=\"#F6223740\" class=\"outlineLink\">Drug Interactions</a></li><li class=\"plainItem\"><a sectionName=\"Food Interactions\" href=\"#F235811\" class=\"outlineLink\">Food Interactions</a></li><li class=\"plainItem\"><a sectionName=\"Pregnancy Risk Factor\" href=\"#F235800\" class=\"outlineLink\">Pregnancy Risk Factor</a></li><li class=\"plainItem\"><a sectionName=\"Pregnancy Implications\" href=\"#F13881520\" class=\"outlineLink\">Pregnancy Implications</a></li><li class=\"plainItem\"><a sectionName=\"Breast-Feeding Considerations\" href=\"#F13881521\" class=\"outlineLink\">Breast-Feeding Considerations</a></li><li class=\"plainItem\"><a sectionName=\"Dietary Considerations\" href=\"#F235808\" class=\"outlineLink\">Dietary Considerations</a></li><li class=\"plainItem\"><a sectionName=\"Monitoring Parameters\" href=\"#F50858837\" class=\"outlineLink\">Monitoring Parameters</a></li><li class=\"plainItem\"><a sectionName=\"Pharmacodynamics/Kinetics\" href=\"#F46169264\" class=\"outlineLink\">Pharmacodynamics/Kinetics</a></li><li class=\"plainItem\"><a sectionName=\"Pricing: US\" href=\"#F235807\" class=\"outlineLink\">Pricing: US</a></li><li class=\"plainItem\"><a sectionName=\"Brand Names: International\" href=\"#F2869420\" class=\"outlineLink\">Brand Names: International</a></li><li class=\"plainItem\"><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"DRUG_GEN/10328|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=DRUG/57469\" class=\"graphic graphic_table\">- Lexicomp clinical abbreviations</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li><a href=\"topic.htm?path=zinc-sulfate-patient-drug-information\" class=\"drug drug_patient\">Zinc sulfate: Patient drug information</a></li><li><a href=\"topic.htm?path=zinc-sulfate-pediatric-drug-information\" class=\"drug drug_pediatric\">Zinc sulfate: Pediatric drug information</a></li></ul></div></div>","javascript":null}